Late-stage biotech company developing potentially curative gene therapies through leveraging its proprietary NAV technology (consists of novel AAV vectors) Generates significant revenue through … [Read more...] about Regenxbio (RGNX)-About
RGNX
An Update on RegenXBio
Previously, our Chief Operating Officer Sultan Beardsley outlined an investment thesis for RegenXBio. This detailed report can be read here: Could This Biotech Stock Get Bought For $5.5 Billion? … [Read more...] about An Update on RegenXBio
Gene therapy treatment for SMA approved! (Full TA)
Gene Therapy for SMA-- Full technical analysis #VolatilityWatch by follow_the_money on TradingView.com RegenexBio (RGNX) and Novartis (NVS) just received FDA approval of Gene Therapy treatment for … [Read more...] about Gene therapy treatment for SMA approved! (Full TA)
You must be logged in to post a comment.